InvestorsHub Logo
Followers 115
Posts 11873
Boards Moderated 0
Alias Born 07/10/2014

Re: None

Tuesday, 09/22/2020 8:24:07 AM

Tuesday, September 22, 2020 8:24:07 AM

Post# of 686787
5yr OS from 5% SOC benefit to Keytruda's 20 to 30% is big for the Unmet need for Lung Cancer. Imagine when our TLD for GBM is in the same range 20-30%, how high we should fly. Looks like 5yr OS 20% is expected from immunotherpy and when we excel, we fly to the Moon!

https://www.webcaster4.com/Player/Index?webcastId=37331&g=adab872d-104d-49c9-a100-24059d246dfe&uid=5472214&sid=

.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News